Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cambridge
Biotech
GSK unveils cost-saving plan to fund R&D, move research HQ
GSK's three-year plan will divert resources to late-stage R&D and shift its research base—but CEO Luke Miels is tight-lipped about job losses.
James Waldron
Jul 28, 2026 9:50am
Takeda consolidates Boston footprint
Feb 11, 2026 3:51pm
AstraZeneca keeps UK research site on pause, but options open
Jan 26, 2026 9:25am
AstraZeneca: Building a transparent pipeline from the ground up
Oct 10, 2025 9:52am
Ono Pharma lays off 83 staffers at Cambridge site
Apr 29, 2025 1:56pm
Growing demand for organ-on-a-chip services prompt CN Bio growth
Jul 20, 2022 9:35am
